Kenneth Anderson
Optometrist · Montevallo, ALNPI 1376534198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for optometrist clinicians in AL, where the typical reported total is $902.
Across 11 payments — averaging $86.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oyster Point Pharma, Inc.$203
- Dompe US, Inc.$202
- Tarsus Pharmaceuticals, Inc.$136
- Alcon$105
- Bausch & Lomb Americas Inc.$100
- Coopervision Inc.$92
- plus $113 from 2 others
What the payments were for
- Food & beverage$951100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oyster Point Pharma, Inc. | 2 | $203 |
| Dompe US, Inc. | 2 | $202 |
| Tarsus Pharmaceuticals, Inc. | 2 | $136 |
| Alcon | 1 | $105 |
| Bausch & Lomb Americas Inc. | 1 | $100 |
| Coopervision Inc. | 1 | $92 |
| Glaukos Corporation | 1 | $57 |
| Carl Zeiss Meditec USA, Inc. | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$951 in reported general payments places this provider in the 50th percentile of 749 optometrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 71 | $34,401 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 23 | $4,302 |
| Brimonidine Tartrate | 21 | $3,715 |
| Latanoprost | 146 | $2,952 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 86 | $2,422 |
| Timolol Maleate | 33 | $344 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Montevallo
- Mark SchaefferHoover$470K
- Kelly NicholsBirmingham$231K
- Benjamin KachelmanFlorence$101K
- Neena JamesHuntsville$74K
- Tracey Schroeder SwartzHuntsville$69K
- Jack SchaefferHoover$60K
- Leo SemesBirmingham$60K
- Brooke KaplanMountain Brk$54K
- Patricia FulmerHuntsville$45K
- David SchaefferHoover$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.